Perkin Elmer has launched the Alphaplex reagent technology, a homogeneous, all-in-one-well multiplexing reagent system for performing ultra-sensitive immunoassay analyses.
The reagents are designed to extract more information from each assay by simultaneously quantifying multiple analytes in a single well. The reagents draw upon the Company’s Alphalisa technology to quantify multiple analytes in a single well. When the Donor and Acceptor beads are brought together, a cascade of chemical reactions is set in motion, causing a greatly amplified signal.
By using multiple Acceptor beads, which emit different wavelengths, multiple analytes can be detected.